Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Diabetes is a group of metabolic diseases in which the person has high blood glucose. It is a long term disorder that causes high blood sugar level Diabetes occurs either because insulin production is scanty in the pancreas, or because the body's cells do not react properly to insulin, or both. It develops when glucose can’t enter the body’s cell to be used as fuel and it occurs due to lack of insulin to unlock the cell or there is no insulin or insulin is there but it’s not functioning properly.
Symptoms of diabetes are often urination, extreme fatigue, unclear vision, slow healing process, obesity, feeling very thirsty and hungry and weight loss in type 1diabetes
Diabetes is a life time disorder that causes a person's blood sugar level to become too high. Diabetes has many complications associated with it. It increases the risk of many serious health problems but with the correct treatment and recommended lifestyle changes, many people with diabetes are able to prevent or delay the onset of complications
Conference Series LLC in the field of Diabetes provides a platform for practitioners, specialists, diagnostic clinicians, researchers, surgeons, as well as industrialists to participate their views at our Neuroscience conferences.
OMICS International is conducting Diabetes conferences every year in the areas like Endocrinology, Diabetes and Metabolic Syndrome.
There are 3 types of diabetes:
Conference Series LLC:
Conference Series LLC Organizes 3000+ Global Conferenceseries Events inclusive of 600+ Conferences, 1200+ Workshops and 1200+ Symposiums Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.
Conference Series LLC with a notion of accelerating scientific discoveries is organizing more than 3000+ Global Events a year and now set to organize world-class symposia and workshops headed with the presence of Nobel laureates, well-known scientists, professors and research directors. Research abstracts are invited from scientists in the particular field where they will be allotted session time to present their data at OMICS International Medical conferences. The abstracts are peer reviewed prior to their acceptance for the conference. All accepted abstracts for the Conference Series LLC scientific conferences will be released as a special issue in the related OMICS International Open Access Journals as conference proceedings. Each accepted abstract will receive a DOI (Digital Object Identifier) provided by CrossRef. At the stretch of our international cruise in elevating the scientific changes around the nook and corner of the world, we have strengthened our place as the iconic scientific organizer in organizing more than 1000+ Global Events with Continuing Medical Education credits and avalanching further with escalating new ideologies for a more significant and intense scientific career for the coming year 2016 in USA, Europe, China, Australia, Dubai, India and Saudi Arabia.
Scope and Importance:
Diabetes is broadly acknowledged as one of the foremost causes of death and incapacity in the United States. It was the sixth leading cause of death in 2000. However, diabetes is likely to be underreported as the underlying cause of death on death certificates. About 65 percent of deaths among diabetic patients are ascribed to heart disease and stroke. Diabetes is accompanied with long-term complications that affect almost every part of the body. The disease often leads to blindness, heart and blood vessel disease, stroke, kidney failure, amputations, and nerve damage. Unrestrained diabetes can complicate pregnancy, and birth defects are more common in babies born to women with diabetes. In 2002, diabetes cost the United States $132 billion.
Diabetic Market Growth:
The global market for diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018. Oral anti-diabetics were the leading category of drugs in 2010 and showed a growth rate of 6.3% from the total global sales. The total sales for insulin products increased significantly as well.
Endocrinology is a specialty of medicine; some would say a sub-specialty of internal medicine, which deals with the diagnosis and treatment of diseases related to hormones. Endocrinology covers such human functions as the coordination of metabolism, respiration, reproduction, sensory perception, and movement. Endocrinology also focuses on the endocrine glands and tissues that secrete hormones. Global endocrinology drugs market is expected to witness lucrative growth over the forecast period owing to rise in incidence rates of endocrine diseases. Growing adolescent populations which are at high risk of development of endocrine gland and associated disorders as a consequence of imbalance in hormones, and increasing prevalence of diabetes are also factors expected to drive growth of this market. Increasing disease inducing unhealthy lifestyle habits such as smoking, high intake of cholesterol, weight gain, and work stress which enhance the incidence rates of endocrine disorders are expected to fuel market growth throughout the forecast period.
Major Diabetes Company List:
QPS Holdings, LLC
ELI Tech Group
Bioaxis Healthcare Ltd.
Randox Laboratories Ltd.
Chiltern International Limited
Accell Clinical Research
AcelRx Pharmaceuticals, Inc.
Alexion Pharma GmbH
apceth GmbH & Co. KG
Fresenius Medical Care AG & Co. KGaA
Hansa Medical AB
Lamellar Biomedical Ltd
ORYX GmbH & Co. KG
F. Hoffmann-La Roche Ltd.
Actelion Pharmaceuticals Ltd
Comprehensive Prosthetics And Orthotics USA
Abott Diabetes Care (Diagnostics)
Bayer Diabetes Care
Bayer Diabetes Care
Bristol Myers- Squibb
Advanced Proteome Therapeutics
Boston Clinical Trials
Entrega (Englight Biosciences)
Human insulin and devices
Matrivax Research & Development
SciFlour Life Sciences (Allied Minds)
Catalent Pharma Solutions